CO IRBETEL FC TAB 300 12.5MG 28 P

Product Overview

Co-Irbetel FC 300/12.5mg is a specialized prescription medication manufactured by Julphar (Gulf Pharmaceutical Industries), designed for the effective management of high blood pressure (hypertension). Each pack contains 28 film-coated tablets, formulated for once-daily dosing to help reduce the risk of serious cardiovascular events such as heart attacks and strokes. This medication combines two active ingredients: Irbesartan, an angiotensin II receptor blocker (ARB), and Hydrochlorothiazide, a thiazide diuretic, working synergistically to lower blood pressure.

Benefits of Use

• Effective Blood Pressure Control: Provides powerful dual action to significantly lower and maintain healthy blood pressure levels.
• Reduced Cardiovascular Risk: Helps protect against heart-related complications, including stroke and heart attack, associated with uncontrolled hypertension.
• Dual Mechanism of Action: Irbesartan relaxes blood vessels, while Hydrochlorothiazide helps the body eliminate excess fluid and salt, leading to comprehensive blood pressure reduction.
• Convenient Dosing: Once-daily administration supports patient adherence to treatment.

How to Use

1. Always take Co-Irbetel FC 300/12.5mg exactly as prescribed by your doctor. Do not adjust the dose without medical advice.
2. Swallow the film-coated tablet whole with a glass of water, with or without food.
3. It is recommended to take the tablet at the same time each day to help maintain consistent blood pressure control.
4. Continue taking this medication even if you feel well, as high blood pressure often has no noticeable symptoms.
5. Regularly monitor your blood pressure as advised by your healthcare provider.

Caution & Warnings

• Prescription Only: Co-Irbetel FC is a prescription medication. Do not use it without consulting a healthcare professional.
• Pregnancy and Breastfeeding: Not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant.
• Kidney and Liver Conditions: Exercise caution or avoid if you have severe kidney or liver disease. Your doctor will assess suitability.
• Electrolyte Imbalance: May affect electrolyte levels (e.g., potassium, sodium). Regular monitoring is crucial.
• Dizziness: May cause dizziness or lightheadedness, especially when starting treatment or increasing dosage. Avoid driving or operating heavy machinery until you know how it affects you.
• Drug Interactions: Inform your doctor about all other medications you are taking, including over-the-counter drugs, supplements, and herbal remedies, to avoid potential interactions (e.g., NSAIDs, lithium, potassium-sparing diuretics).
• Allergies: Do not use if you are allergic to Irbesartan, Hydrochlorothiazide, or any other ingredients in the tablets.
• Diabetic Patients: Special care is needed for diabetic patients.

Ingredients

• Irbesartan: 300 mg
• Hydrochlorothiazide: 12.5 mg
• (Excipients: q.s. - specific excipients may vary by manufacturer, refer to package leaflet)

Product Details

• Form: Film-Coated Tablets
• Strength: 300 mg Irbesartan / 12.5 mg Hydrochlorothiazide
• Pack Size: 28 Tablets
• Manufacturer: Julphar (Gulf Pharmaceutical Industries)
• Drug Type: Prescription Medicine
• Administration Route: Oral